Lack of association between flow-mediated endotheliumdependent vasodilatation and biomarkers of endothelial dysfunction in patients with severe rheumatoid arthritis

Rheumatology International

Volumn 32, Issue 12, 2012, Pages 4071-4072

  González Gay, Miguel A ^a   González Juanatey, Carlos ^b   Miranda Filloy, José A ^b   García Unzueta, Maria T ^a   Llorca, Javier ^c,d  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED ENDOTHELIUM DEPENDENT VASODILATATION; LASER DOPPLER FLOWMETRY; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VASODILATATION;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; SELECTINS; SEVERITY OF ILLNESS INDEX; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 84872265504     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2254-7     Document Type: Letter

References (10)

1. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: A disease associated with accelerated atherogenesis. Semin Arthr Rheum 35:8-17
2. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, Hajeer AH, Ollier WE, Mattey DL, Gonzalez-Gay MA (2003) HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114: 647-652
3. Galarraga B, Belch JJ, Pullar T, Ogston S, Khan F (2010) Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. J Rheumatol 37:521-528
4. De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F, Pedrinelli R (1997) Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 17:2646-2654
5. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation 96:4219-4225
6. Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthr Res Ther 7:R634-R643
7. Gonzalez-Juanatey C, Llorca J, Sanchez-Andrade A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2006) Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol 24:309-312
8. Gonzalez-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J (2006) Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:373-379
9. Meyer MF, Schmidt O, Hellmich B, Schatz H, Klein HH, Braun J (2007) Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: Relationship to soluble adhesion molecules and extraarticular manifestations. Rheumatol Int 28:145-152
10. González-Juanatey C, Llorca J, González-Gay MA (2011) Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthr Res Ther 13(3):R101